IQVIA (IQV)
NYSEHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$267.77-1.42%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · IQV
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -3.3% |
| Our one-year growth estimate | diamond | 6.3% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 9.7 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 32 industry peers
IQV — debt issuance
Dated 2026-06-11
Entry into a Material Definitive Agreement Notes Offering and Notes Indenture On June 11, 2026, IQVIA Inc. (the “Issuer”), a wholly owned subsidiary of IQVIA Holdings Inc. (the “Company”), completed the issuance and sale of €950,000,000 in gross proceeds of 4.625% senior notes due 2033 (the “Notes”). The Notes were issued pursuant to an Indenture, dated June 11, 2026 (the “Indenture”), among the Issuer, U.S. Bank Trust Company, National Association, as trustee of the Notes, and certain subsid…
Why it matters: This growth rate is a key indicator of demand and operational health in R&D Solutions. A drop below this level could signal weakening performance.
Worry ifR&D Solutions revenue growth exceeds 6.5% year over year in Q3.
Less concerning ifR&D Solutions revenue growth falls below 6.5% year over year in Q3.
Why it matters: Higher EPS guidance means strong earnings. It also shows management is confident.
Supportive ifAdjusted Diluted EPS guidance is now above $12.95.
Worry ifAdjusted Diluted EPS guidance remains at or below $12.65.
Why it matters: Slower backlog growth may show weaker demand for IQVIA's services.
Worry ifR&D Solutions backlog growth rate is below 7.5% year-over-year.
Less concerning ifBacklog growth rate remains above 7.5%, indicating strong demand.
Why it matters: A bigger share buyback shows trust in the company's finances.
Supportive ifManagement boosts share buyback plan to over $2 billion.
Worry ifNo rise in share buyback plan may mean money management problems.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$138 on $10,000 · ±1.4% | How much price usually moves either way. |
| Bad day | $321 loss on $10,000 · 3.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,587 loss on $10,000 · 35.9% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: More share buybacks show management believes in the company's value. This can help stock price.
Supportive ifIQVIA announces share buybacks over $500 million in Q3.
Worry ifIQVIA announces share buybacks below $500 million in Q3.
Why it matters: The revenue guidance shows management is confident in growth. This helps set investor hopes.
Supportive ifManagement says the revenue for 2026 will be between $15.325 billion and $15.575 billion.
Worry ifManagement cuts the revenue guidance for 2026 to less than $15.325 billion.
Why it matters: More buybacks can show management's confidence in the company's value and future.
Supportive ifTotal share repurchases exceed $1 billion for the full year 2026.
Worry ifShare repurchases total less than $800 million for the full year 2026.
Why it matters: A slowdown in revenue growth could signal weakening demand or market challenges.
Worry ifQ2 2026 revenue growth was less than 6% compared to last year.
Less concerning ifQ2 2026 revenue growth was more than 6% compared to last year.
Why it matters: A bigger backlog shows strong future revenue and demand for services.
Supportive ifR&D Solutions backlog was more than $34 billion.
Worry ifR&D Solutions backlog was less than $34 billion.
Why it matters: Reaffirming revenue guidance shows confidence in future performance. It can boost investor trust.
Supportive ifIQVIA confirms full-year 2026 revenue guidance of $17,150 million to $17,350 million in the next earnings call.
Worry ifIQVIA lowers or withdraws its 2026 revenue guidance.
Why it matters: Strong bookings indicate growth momentum in the R&D Solutions segment. This can boost investor confidence.
Supportive ifNet new bookings for R&D Solutions exceed $3.1 billion in the next quarter.
Worry ifNet new bookings are under $2.5 billion. This shows demand is weakening.
Why it matters: Strong cash flow helps with investments and share buybacks. This shows financial health.
Supportive ifOperating cash flow exceeds $500 million in the next quarter.
Worry ifOperating cash flow is below $400 million. This raises concerns about cash generation.